Advisory Committee

Ralph G. Dacey, Jr., M.D, currently serves as the Edith R. and Henry G. Schwartz Professor, Chairman of the Department of Neurological Surgery at Washington University School of Medicine in St. Louis, Missouri. He is the former Chairman of The American Board of Neurological Surgery and Past President of the Congress of Neurological Surgeons. Dr. Dacey is a member of the Advisory Council of the National Institutes of Health’s National Institute for Neurological Disease and Stroke. He sits on committees of the American Association of Neurological Surgeons, the American Academy of Neurological Surgeons and the Society of Neurological Surgeons. He is a past chairman of the editorial board of the Journal of Neurosurgery and currently serves on the editorial boards of Neurosurgery and Perspectives in Neurological Surgery. Dr. Dacey currently serves on the Board of Directors of Stereotaxis, Inc., a publicly-held company which is also a portfolio company of Oakwood I. Dr. Dacey earned a B.A. from Harvard University and an M.D. from the University of Virginia.

Arda M. Minocherhomjee, Ph.D., is a founding Partner of Chicago Growth Partners. Prior to founding CGP, Dr. Minocherhomjee was a Managing Director at William Blair Capital Partners and, currently, is a Managing Director and member of the Board of Managers of WBCP VI and VII. Prior to that, Dr. Minocherhomjee was a Senior Healthcare Analyst at William Blair & Company. As head of the firm’s Healthcare Research Group, Dr. Minocherhomjee covered several sectors, including drugs/drug delivery, medical devices and selected healthcare services. He was a Wall Street Journal “All-Star Analyst” in both medical device and pharmaceutical sectors. Select current and past directorships include: AtheroGenics, CryoCor, DJ Pharma, EndoGastric Solutions, Favrille, Genoptix, Morton Grove Pharmaceuticals, NuVasive, PharmaResearch Corporation, POINT Biomedical, Proteome and TargeGen. Dr. Minocherhomjee received a M.S. (Pharmacology) from the University of Toronto, a Ph.D and a MBA from the University of British Columbia, and was a post-doctoral fellow in Pharmacology at the University of Washington Medical School.